Thus, the higher Wnt3a expression and simultaneous downregulation of Wnt4, as reported herein, appear to be involved in the compensatory mechanism of lipid-induced insulin resistance in skeletal muscle and WAT. The gene discussed is WNT3A; the disease is Insulin resistance.